Depression Clinical Trial
Official title:
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Verified date | December 2015 |
Source | University of Miami |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Among adolescents, SAD and depression are prevalent, highly comorbid, and can be chronic and
impairing. Interpersonal peer victimization (IPV) is a key stressor that contributes to both
social anxiety and depression in adolescents; it includes relational (e.g., social
exclusion) and reputational (e.g., spreading rumors) forms of peer victimization. Currently,
there are no preventive interventions for adolescent SAD. Also, effective preventive
interventions for adolescents have not yet integrated a focus on both social anxiety and
depression or targeted specific peer risk factors. Interventions for depression and for
bullying have not addressed IPV, which is less observable than overt victimization (e.g.,
threats, physical acts).
Thus, the Peers Emotions and Relationships (PEERS/UTalk) intervention, will take an
integrated approach to reducing risk for SAD and depression by modifying and adapting an
evidence-based intervention for depression, Interpersonal Psychotherapy- Adolescents Skills
Training (IPT-AST), that focuses on improving interpersonal skills and managing conflict. We
will add a) elements of anxiety-based treatments (e.g., exposures) and b) strategies for
handling challenging peer experiences. PEERS/UTalk will have a positive focus and will
target adolescents who report elevated symptoms of social anxiety and/or depression and high
levels of IPV.
Following are the aims and hypotheses of the Pilot-Randomized Controlled Trial:
Aim: Evaluate PEERS/UTalk. We will screen adolescents and conduct a pilot randomized trial
of PEERS (U Talk) versus an Education/Support (ES) condition with up to 60 "high-risk"
adolescents.
Hypothesis 1: Both PEERS/UTalk and ES conditions will demonstrate: (a) feasibility via rates
of participation and study completion, (b) intervention credibility via adolescents' ratings
of acceptability and satisfaction, and (c) high rates of clinician fidelity to the
respective manuals.
Hypothesis 2: Adolescents randomized to PEERS/UTalk will show improvements in primary
outcomes (less IPV, fewer symptoms of social anxiety and depression, improved clinician
ratings) relative to those in the ES condition.
Hypothesis 3: The benefits of PEERS/UTalk over ES will be apparent on the secondary outcomes
of increased quality of close friendships, increased peer support.
Exploratory Aims: We will examine: (1) the durability and persistence of PEERS/UTalk
intervention effects versus ES on primary outcomes at 6-month follow-up and (2) potential
moderators of response to the PEERS/UTalk intervention, recognizing that there are power
limitations in doing so.
Status | Completed |
Enrollment | 49 |
Est. completion date | June 2015 |
Est. primary completion date | May 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 13 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Male and female adolescents, ages 13-18 years (inclusive) and in grades 9, 10, or 11. - Participants must be sufficiently fluent in English (by their own self-report) to complete measures and intervention programs in this language. - Participants must report elevated levels of relational PV and/or reputational PV on screening measures (R-PEQ); i.e., adolescents must obtain a total score > or = to 6 on the relational and/or reputational subscales of the R-PEQ. - Participants must report symptoms of social anxiety and/or depression that exceed clinical cutoffs on the Social Anxiety Scale for Adolescents (SAS-A > or = to 50) or the Center for Epidemiologic Studies-Depression Scale (CES-D > or = to 16). Exclusion Criteria: - Enrollment in special education services (e.g., for learning disabilities, mental retardation, pervasive developmental disorder). - Adolescents must not exceed clinical cutoffs (t score > 63) on the Aggression Subscale of the Youth Self Report (YSR). - Adolescents must not report elevated levels (score >6) on the overt peer victimization scale of the R-PEQ. - Adolescents must not currently meet diagnostic criteria for a social anxiety or depressive disorder as determined by the Anxiety Disorders Schedule for Children (ADIS-IV-C). - Adolescents must not currently meet criteria for PTSD, bipolar disorder, psychosis, or an eating, substance use, or conduct disorder on the ADIS-IV-C. - Adolescents must not endorse active suicidal items on the Columbia Suicide Severity Rating Scale (C-SSRS). - Adolescents must not be currently receiving treatment for social anxiety or depressive disorder. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | University of Miami | Coral Gables | Florida |
Lead Sponsor | Collaborator |
---|---|
University of Miami | Columbia University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Anxiety Disorder Interview Schedule- Children (ADIS-C) | Baseline, Change from baseline in Clinician Severity Rating at 12 weeks and at 6 month follow up for Social Anxiety Disorder and Major Depressive Disorder | No | |
Primary | Clinicians Global Impression Scale (Severity and Improvement) | Baseline, Change from baseline at 12 weeks, and at 6 month follow up | No | |
Primary | Revised Peer Experiences Questionnaire (subscales for Relational and Reputational PV) | Screening, Baseline, Change from baseline at 12 weeks, and at 6 month follow up | No | |
Secondary | Social Anxiety Scale for Adolescents | Screening, Baseline, Change from baseline at 12 weeks, and at 6 month follow up | No | |
Secondary | Centers for Epidemiological Studies Depression Scale | Screening, Baseline, Change from baseline at 12 weeks, and at 6 month follow up | No | |
Secondary | Perceived Support Scale- Friends and Family | Baseline, Change from baseline at 12 weeks, and at 6 month follow up | No | |
Secondary | Cyber Peer Experiences Questionnaire | Screening, Baseline, Change from baseline at 12 weeks, and at 6 month follow up | No | |
Secondary | Revised Peer Experiences Questionnaire | Screening, Baseline, Change from baseline at 12 weeks, and at 6 month follow up | No | |
Secondary | Health Behaviors | Screening, Baseline, Change from baseline at 12 weeks, and at 6 month follow up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |